美國
US 12,697,370 B2
PSG1 for use in the treatment of osteoarthritis
US 12,697,370 B2 是美國專利商標局（USPTO）的核准專利，日期 2026-08-04。申請人：UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK。PDF 可在本頁下載，未登入每天最多 5 篇。
- 申請人
- UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
- 發明人
- Tom Moore; Anthony James Peterson Clover
- 公開日
- 2026-08-04
- 申請日
- 2023-10-13
- 文件種類
- B2 核准公告
- 也寫作
- US 12,697,370 B2 · US12697370 · 12697370
摘要
The use of Fc-tagged Pregnancy-specific glycoprotein 1 (PSG1-Fc) in a method of treatment of osteoarthritis or damaged cartilage in a human, in which the PSG1 is administered by intra-articular injection, is described. Also described is the use of CC49 in a method of treatment of osteoarthritis or damaged cartilage in an equine mammal, in which the CC49 is administered by intra-articular injection. (FIG. 3A-C) Also described is the use of PSG1 in a method of treatment of wounds, scarring, burns and diabetic ulcers in a mammal.
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）